Skip to content

Evaluation of human amniotic membrane on reducing post-surgical adhesions

Evaluation of human amniotic membrane on reducing post-surgical adhesions

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230917059448N1
Enrollment
40
Registered
2023-11-03
Start date
2023-10-23
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Post-surgical pelvic peritoneal adhesions. Condition 2: Endometriosis. Post-surgical pelvic peritoneal adhesions Endometriosis

Interventions

Intervention 1: Intervention group: administration of amniotic patch on the adhesion location during surgery. Intervention 2: Control group: Intervention group: not administration of amniotic patch on

Sponsors

Tehran university of medical sciences
Lead Sponsor
Sinacell company
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: DIE in trans vaginal or trans rectal sonography surgical treatment candidate age 18-45 years no desire to pregnancy in next 3 mounths

Exclusion criteria

Exclusion criteria: no satisfy to participation active infection pregnancy or breastfeeding cardiovascular, gastrointestinal or hormonal illnesses auto immune illnesses like SLE , etc. genital system inflammations involvement to cancer in the past and present positive serology for HBS, HCV, HIV, HTLV

Design outcomes

Primary

MeasureTime frame
Endometriosis post surgical laparoscopic adhesions. Timepoint: 3 months after surgery and amniotic patch. Method of measurement: sonography and second look surgery.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Farhoodi

Tehran University of Medical Sciences

dr.shirinfarhoodi@gmail.com+98 21 7788 3283

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026